An efficient strategy to induce and maintain in vitro human T cells specific for autologous Non-Small Cell Lung Carcinoma

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Canderan, Glenda ^a,d   Gruarin, Paola ^a,e   Montagna, Daniela ^b   Fontana, Raffaella ^a   Melloni, Giulio ^a   Traversari, Catia ^c   Dellabona, Paolo ^a   Casorati, Giulia ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c MOLMED S P A   (Italy)

^d Vaccine and Gene Therapy Institute Florida (VGTI FL)   (United States)

^e Istituto Nazionale di Genetica Molecolare   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CLONE; CELL ISOLATION; CELL LINE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IRRADIATION; LUNG NON SMALL CELL CANCER; LYMPHOCYTIC INFILTRATION; PROTEIN EXPRESSION; ALLOTRANSPLANTATION; ANIMAL; ANTIGEN PRESENTATION; CELL PROLIFERATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LUNG TUMOR; METABOLISM; MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGEN PRESENTATION; CARCINOMA, NON-SMALL-CELL LUNG; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL PROLIFERATION; CLONE CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; RECEPTORS, ANTIGEN, T-CELL; TRANSPLANTATION, HOMOLOGOUS;

EID: 77957777981     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012014     Document Type: Article

References (42)

1. Dunn GP, Old LJ, Schreiber RD (2004) The three Es of cancer immunoediting. Annu Rev Immunol 22: 329-360.
2. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, et al. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643-1647.
3. Van Der Bruggen P, Zhang Y, Chaux P, Stroobant V, Panichelli C, et al. (2002) Tumor-specific shared antigenic peptides recognized by human T cells. Immunol Rev 188: 51-64.
4. Boel P, Wildmann C, Sensi ML, Brasseur R, Renauld JC, et al. (1995) BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2: 167-175.
5. Herbst RS, Heymach JV, Lippman SM (2008) Lung cancer. N Engl J Med 359: 1367-1380.
6. Mami-Chouaib F, Echchakir H, Dorothee G, Vergnon I, Chouaib S (2002) Antitumor cytotoxic T-lymphocyte response in human lung carcinoma: identification of a tumor-associated antigen. Immunol Rev 188: 114-121.
7. Knuth A, Danowski B, Oettgen HF, Old LJ (1984) T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures. Proc Natl Acad Sci USA 81: 3511-3515.
8. Mukherji B, MacAlister TJ (1983) Clonal analysis of cytotoxic T cell response against human melanoma. J Exp Med 158: 240-245.
9. Vanky F, Gorsky T, Gorsky Y, Masucci MG, Klein E (1982) Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor. J Exp Med 155: 83-95.
10. Fossati G, Taramelli D, Balsari A, Bogdanovich G, Andreola S, et al. (1984) Primary but not metastatic human melanomas expressing DR antigens stimulate autologous lymphocytes. Int J Cancer 33: 591-597.
11. Vose BM, White W (1983) Tumour-reactive lymphocytes stimulated in mixed lymphocyte and tumour culture. Clonal analysis of effector cells in cytotoxic and proliferative assays. Cancer Immunol Immunother. pp 227-236.
12. Anichini A, Fossati G, Parmiani G (1986) Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones. J Exp Med 163: 215-220.
13. Hoffmann TK, Meidenbauer N, Dworacki G, Kanaya H, Whiteside TL (2000) Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells. Cancer Res 60: 3542-3549.
14. Tabi Z, Moutaftsi M, Borysiewicz LK (2001) Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens. J Immunol 166: 5695-5703.
15. Montagna D, Maccario R, Locatelli F, Rosti V, Yang Y, et al. (2001) Ex vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy. Blood 98: 3359-3366.
16. Berard F, Blanco P, Davoust J, Neidhart-Berard EM, Nouri-Shirazi M, et al. (2000) Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J Exp Med 192: 1535-1544.
17. Russo V, Tanzarella S, Dalerba P, Rigatti D, Rovere P, et al. (2000) Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response. Proc Natl Acad Sci USA 97: 2185-2190.
18. Johnson LA, Heemskerk B, Powell DJ Jr, Cohen CJ, Morgan RA, et al. (2006) Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumorinfiltrating lymphocytes. J Immunol 177: 6548-6559.
19. Abad JD, Wrzensinski C, Overwijk W, De Witte MA, Jorritsma A, et al. (2008) T-cell receptor gene therapy of established tumors in a murine melanoma model. J Immunother 31: 1-6.
20. Kessels HW, Wolkers MC, van den Boom MD, van der Valk MA, Schumacher TN (2001) Immunotherapy through TCR gene transfer. Nat Immunol 2: 957-961.
21. Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, et al. (2006) Cancer regression in patients after transfer of genetically enginnered lymphocytes. Science 314: 126-129.
22. Stauss HJ, Cesco-Gaspere M, Thomas S, Hart DP, Xue SA, et al. (2007) Monoclonal T-cell receptors: new reagents for cancer therapy. Mol Ther 15: 1744-1750.
23. Cohen CJ, Zhao Y, Zheng Z, Rosenberg SA, Morgan RA (2006) Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability. Cancer Res 66: 8878-8886.
24. Hart DP, Xue SA, Thomas S, Cesco-Gaspere M, Tranter A, et al. (2008) Retroviral transfer of a dominant TCR prevents surface expression of a large proportion of the endogenous TCR repertoire in human T cells. Gene Ther 15: 625-631.
25. Stanislawski T, Voss RH, Lotz C, Sadovnikova E, Willemsen RA, et al. (2001) Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat Immunol 2: 962-970.
26. Kaneko S, Mastaglio S, Bondanza A, Ponzoni M, Sanvito F, et al. (2009) IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive selfrenewing central memory human T lymphocytes. Blood 113: 1006-1015.
27. Flamand L, Crowley RW, Lusso P, Colombini-Hatch S, Margolis DM, et al. (1998) Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis. Proc Natl Acad Sci USA 95: 3111-3116.
28. Dorrschuck A, Schmidt A, Schnurer E, Gluckmann M, Albrecht C, et al. (2004) CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression. Blood 104: 2591-2599.
29. Bradley LM, Haynes L, Swain SL (2005) IL-7: maintaining T-cell memory and achieving homeostasis. Trends Immunol 26: 172-176.
30. Weiss JM, Subleski JJ, Wigginton JM, Wiltrout RH (2007) Immunotherapy of cancer by IL-12-based cytokine combinations. Expert Opin Biol Ther 7: 1705-1721.
31. Del Vecchio M, Bajetta E, Canova S, Lotze MT, Wesa A, et al. (2007) Interleukin-12: biological properties and clinical application. Clin Cancer Res 13: 4677-4685.
32. Rickinson AB, Moss DJ (1997) Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 15: 405-431.
33. Levitsky V, de Campos-Lima PO, Frisan T, Masucci MG (1998) The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time. J Immunol 161: 594-601.
34. Thomas S, Xue SA, Cesco-Gaspere M, San Jose E, Hart DP, et al. (2007) Targeting the Wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cells. J Immunol 179: 5803-5810.
35. Gilbert SF, Migeon BR (1975) D-valine as a selective agent for normal human and rodent epithelial cells in culture. Cell 5: 11-17.
36. Mavilio F, Ferrari G, Rossini S, Nobili N, Bonini C, et al. (1994) Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 83: 1988-1997.
37. Montagna D, Maccario R, Locatelli F, Montini E, Pagani S, et al. (2006) Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemia. Blood 108: 3843-3850.
38. Vavassori M, Maccario R, Moretta A, Comoli P, Wack A, et al. (1996) Restricted TCR repertoire and long-term persistence of donor-derived antigenexperienced CD4+ T cells in allogeneic bone marrow transplantation recipients. J Immunol 157: 5739-5747.
39. Genevee C, Diu A, Nierat J, Caignard A, Dietrich PY, et al. (1992) An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol 22: 1261-1269.
40. Wack A, Montagna D, Dellabona P, Casorati G (1996) An improved PCRheteroduplex method permits high-sensitivity detection of clonal expansions in complex T cell populations. J Immunol Methods 196: 181-192.
41. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, et al. (1998) A thirdgeneration lentivirus vector with a conditional packaging system. J Virol 72: 8463-8471.
42. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15: 871-875.